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Importance of recognizing and managing delirium in in-
tensive care unit
XIE Guo-hao谢郭豪 and FANG Xiang-ming方向明*
Delirium is an acute and fluctuating change in mental
status, with inattention and altered levels of consciousness.
It is a common comorbidity in intensive care units (ICU),
resulting in delayed withdrawal of mechanical ventilation,
prolonged length of stay in ICU, increased ICU mortality
and impaired long-term cognitive function of the survivors.
Narcotic or psychoactive medication is one of the major risk
factors that contribute to ICU delirium. Surveys conducted
in several countries indicated that delirium in ICU was inad-
equately monitored, underdiagnosed and lacked standard-
ized treatment. In order to improve the prevention and treat-
ment of ICU delirium, it is imperative that the ICU profes-
sionals should enrich their knowledge about this
comorbidity, familiarize themselves with its screening and
management, as well as standardize the administration of
narcotic and psychoactive medications.
Key words:    Intensive care units; Critical care; De-
lirium
With advances in the diagnostic technolo-gies and life-supporting systems in criticalcare medicine, an increasing population of
severely ill patients has survived in the intensive care
units (ICU). Monitoring patients’organs and systems
and supporting or reversing their failure organs are rou-
tine tasks of ICU professionals. However, brain is usu-
ally less centered than other major organs (e.g. the
heart, the lungs, etc.) in ICU. As a form of acute brain
dysfunction, delirium has not got extensive attention
from physicians, nurses and therapists in ICU until this
decade.
Delirium is an acute and fluctuating change in men-
tal status, with inattention and altered levels of
consciousness.1,2 It is a common syndrome that mostly
affects geriatric patients or patients with critical illness.
Unfortunately, delirium along with critical illness, or ICU
delirium, has been grossly under-recognized by ICU
clinicians in the past, and has been referred to by vari-
ous terms in literature, such as “ICU psychosis”, “acute
brain dysfunction”, “encephalopathy of critical illness”,
and so on. Some practitioners believed that ICU de-
lirium is a transient, non-organic, inconsequential and
totally reversible neuropsychological syndrome without
any need of specific intervention.3 In recent years, as
objective approaches of detecting delirium have been
proposed and validated by a series of investigations, a
number of studies indicated that ICU delirium is asso-
ciated not only with high incidence but also with worse
ICU outcome and long-term cognitive impairment.4-13
Therefore, investigating the pathophysiological process
of ICU delirium as well as its preventing and treating
strategies may help improve both the ICU outcome and
the long-term cognitive function in critical illness.
Epidemiology of ICU delirium
Several epidemiological studies conducted in mul-
tiple countries found that delirium develops in 20%-50%
of lower-severity ICU patients or those receiving no
mechanical ventilation, and 60%-80% of ICU patients
with mechanical ventilation.4-9 Most of time delirium de-
velop unobtrusively in ICU, for it is usually considered
as “dementia”, “depression” or even expected as “part
of the scenery” in the critically ill patients.14,15 Many
ICU clinicians expect delirium to present with agitation
or hallucination, therefore, patients with “hypoactive
delirium”, which is characterized with decreased men-
tal and physical activities and inattention, have been
severely under-diagnosed.16,17 Peterson et al18 had found
in a cohort study of 613 ICU patients within one year
that among the patients experiencing delirium, pure hy-
peractive delirium was rare (1.6%), whereas hypoactive
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and mixed subtypes of deliria accounted for the vast
majority. In China, though no multi-centered epidemio-
logical investigations on ICU delirium are available by
now, some studies have reported that approximately
11.8%-16.3% of the geriatric patients developed delirium
postoperatively.19,20
Pathophysiological mechanisms of ICU delirium
The brain has its own inflammatory reactions, in-
cluding production and release of cytokines, cell infil-
tration and tissue damage in response to systemic in-
fections or other harmful stimulations (hypoxia, cere-
bral hypo-perfusion, etc).21,22 These inflammatory re-
sponses of brain are thought to alter the patterns of
local neuronal activities, therefore resulting in delirium.
Though the detailed mechanisms and pathways of de-
lirium are still not well understood, experts of neuro-
science thought that they are related to the imbalances
of neurotransmitters involved in the modulation of cog-
nitive function, behavior and mood.23-27 Dopamine, ace-
tylcholine and γ -aminobutyric acid (GABA) are the
three major neurotransmitters considered to be related
with delirium. In general,  excess of dopamine and
depletion of acetylcholine are two main changes of the
neurotransmitter system in the development of delirium.
In addition, imbalance or dysfunction of other
neurotransmitters, such as serotonin, endorphin and
noradrenalin, is also reported to induce delirium.24,27
In a neuroimaging study, Koponen et al28 found sig-
nificant ventricular enlargement and generalized atro-
phy in the brain of delirious patients compared with the
controls. Suchyta et al29 also reported that among criti-
cally ill patients who underwent brain CT scan for al-
tered levels of consciousness, impaired cognitive func-
tion or prolonged delirium, 61% had abnormal findings,
including atrophy, ventricular enlargement, white mat-
ter lesions and cortical/subcortical lesions. These struc-
tural changes in the central nervous system may be
the pathological ground of the long-term cognitive im-
pairment in the ICU survivors, especially in those with
experience of ICU delirium.
Risk factors for ICU delirium
Besides traditional risk factors of delirium, includ-
ing age, previous neurocognitive disorder, comorbidity,
severity of illness, sepsis, hypoxia and metabolic
derangements, narcotic or psychoactive medication is the
predominant and characteristic risk factor in ICU. Inouye
et al30 summarized in a review that benzodiazepines, opio-
ids and several psychoactive drugs were associated
with a 3-11-fold increase in relative risk of delirium.
Marcantonio et al31 found that diazepam and pethidine
were closely correlated with ICU delirium. In another
study, Pandharipande et al32 concluded that the use of
lorazepam was an independent risk factor of ICU
delirium. The same group also found that the adminis-
tration of midazolam was a strong predictor of delirium
in surgical and trauma ICU patients.8 In addition, sleep
deprivation or loss of circadian rhythm is also thought
to be a potential risk factor of ICU delirium, whereas
the mechanism involved still needs to be illuminated by
further studies.33
ICU delirium and prognosis
ICU delirium is a neither benign nor self-limited
disease. In fact, it is associated with a series of ad-
verse outcomes. In two prospective cohort studies on
mechanical ventilated patients, Ely et al10 and Lin et al7
found that ICU delirium was an independent predictor
of mortality, which inflicted patients a 3-fold increase in
the risk of death. Other studies indicated that ICU de-
lirium was also related with an increased risk of
reintubation, prolonged length of stay in ICU and hospital,
as well as higher medical expenditures.34-38 Delirium
risks are thought to be cumulative: each additional day
spent with delirium is associated with a 20% increased
risk of prolonged length of stay in hospital and a 10%
increased risk of death. And 10% -24% of patients with
persistent delirium would have long-term cognitive
disorders.4,10,39 However, whether ICU delirium is the di-
rect cause of these adverse consequences or merely a
clinical manifestation of the real cause is still unknown,
which needs to be explored in well-designed and pro-
spective cohort studies in the future.
Monitoring ICU delirium
The “2002 guidelines of the Society of Critical Care
Medicine (SCCM) for sedation and analgesia” under-
lined the importance of monitoring the levels of seda-
tion and delirium simultaneously of critical illness.40 In
daily practice, ICU physicians and nurses should first
assess a patient’s level of consciousness/sedation with
specific tools, mainly including Ramsay scale, seda-
tion agitation scale and Richmond agitation sedation
scale.40-42 Evaluation of the sedation level would not only
avoid over-sedation and help the patients liberate from
the ventilators earlier, but also tell the clinicians which
Chinese Journal of Traumatology 2009; 12(6):370-374. 372 .
patients should be screened for delirium. All patients
(neither in over-sedation nor in coma) who are respon-
sive to verbal stimuli should be assessed for delirium.
Currently, there are two major assessment tools for
ICU delirium, including the intensive care delirium
screening checklist and the confusion assessment
method for the ICU (CAM-ICU).43,44 The latter has been
welcomed by the critical care clinicians and widely used
in ICU in these years, for its high sensitivity and speci-
ficity (both around 95%), as well as its simplicity, which
makes it feasible for non-psychiatric clinicians to per-
form routine bedside screening.
Preventing and treating strategies of ICU delirium
Firstly, ICU clinicians should have a thorough un-
derstanding of delirium and consider it as a severe
comorbidity that should be promptly intervened. Sev-
eral surveys conducted in the western countries indi-
cated that delirium still has not been intensively cen-
tered in the daily ICU practice. In 2001, Ely et al45 ques-
tioned 912 ICU physicians, nurses and therapists who
were attending critical care meetings or continuing
medical education. And they found that 60% of the re-
spondents thought that delirium was common in the
ICU (with the incidence >25%), 24% agreed that it was
a normal part of ICU hospitalization, and only 29%
thought that it could be prevented or partly prevented.
Among the 912 surveyed participants, 78% recognized
delirium being under-diagnosed in the ICU currently,
40% reported routine screening for delirium, yet only
27% conducted daily screening and 6% reported screen-
ing for delirium with specific assessment tools, includ-
ing the mini mental state examination, the Glasgow
coma scale, the sedation scales and the CAM-ICU.
Five years later, a paralleled questionnaire was carried
out and it found that the ICU clinicians attached signifi-
cantly more importance to delirium.46 In this survey,
59% of the respondents reported routine screening for
delirium and 20% used specific tools. The significant
changes in the ICU professionals’ attitudes and behav-
iors towards delirium are coincident with the fact that
ICU delirium has become a hot spot both in the basic
and clinical study of critical care medicine. In addition,
another study also reported that only 14% of the Dutch
ICU regularly monitored delirium, while half of these ICU
used specific assessment tools.47 In China, a similar
survey has been conducted recently in the ICU of two
university hospitals and it found that delirium is still
severely under-recognized and lacks adequate moni-
toring and standardized interventions in the Chinese
ICU. Of the questioned clinicians in the two hospitals,
only 42% and 56% thought that more than 25% of the
ICU patients or patients receiving mechanical ventila-
tion experienced delirium, respectively. Fifty-six per-
cent of the respondents agreed that delirium was un-
der-diagnosed, but only 5% had randomly screened pa-
tients for delirium. Although 81% of the surveyed clini-
cians agreed that patients with delirium needed active
and prompt interventions, most of them confessed that
they had no idea of how to treat this comorbidity, and
only 32% mentioned haloperidol or olanzapine. These
results indicate a pressing need for the ICU profession-
als to update their knowledge of delirium and familiar-
ize themselves with theories, guidelines and research
advances of delirium, for the prevention and treatment
of ICU delirium would not be ultimately improved only
after various ignorances, biases and misunderstand-
ings towards delirium are corrected.
Secondly, all potential risk factors that lead to de-
lirium should be minimized in ICU. Sepsis, hypoxia and
other situations that have adverse impacts on the brain
function should be identified and treated in time. Moreover,
objective aims and standardized protocols for sedation
and analgesia should be adopted in order to minimize
the use of narcotic and psychoactive medications. Also,
novel sedatives like dexmedetomidine, a kind of α-re-
ceptor agonist, should be considered as a replacement
of the traditional potent GABA-receptor agonists. A re-
cently-conducted randomized, blinded, and multi-cen-
tered study showed that patients sedated with
dexmedetomidine experienced significantly fewer epi-
sodes of delirium compared with those sedated with
midazolam, which indicated a promising future of these
novel sedatives in ICU.48 In addition, sleep deprivation
should be avoided and plans that can help patients
maintain their circadian rhythms should be established.
Thirdly, patients with delirium or high risk of delirium
should be promptly intervened. For those at high risks,
non-pharmacological approaches are mainly adopted,
including helping patients better receive information from
the environment via use of eyeglasses and hearing aids,
reestablishing their orientation via communication and
early mobilization activities, diminishing adverse stimu-
lants via withdrawal of ventilators and removal of vari-
ous tubes/catheters.49 For the patients with delirium,
pharmacological treatment usually cannot be omitted.
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Although haloperidol is the most frequently-used em-
pirical agent in clinical practice, it has not been ap-
proved by the United States Food and Drug Adminis-
tration for treatment of delirium, nor have any other
medications. With adverse effects including extrapyra-
midal symptoms, prolongation of the Q-T interval,
torsades de points and neuroleptic malignant syndrome,
haloperidol should be administered with great caution
in critically ill patients. Olanzapine and other atypical
antipsychotics have also been reported for treating
delirium, while the extensive use of these agents is still
controversial for they may potentially increase death
risk.50,51 Therefore, the research and development of new
drugs and therapies treating delirium will be central in
the near future.
In summary, delirium is a common comorbidity in
critically ill patients and is associated with prolonged
hospitalization, higher medical expenditures, increased
mortality and long-term cognitive impairment of the ICU
survivors. It is imperative for ICU professionals to have
a thorough understanding of delirium and optimize its
monitoring and management, by which, more critically
ill patients will survive and have a better quality of life.
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